gabermarketing

20
Jun

Dr. Bärbel Rohrer Joins Ichor Therapeutics’ Scientific Advisory Board

LaFayette, NY, June 20, 2016 –  Ichor Therapeutics, Inc a biotech contract research firm specializing in age-related diseases, adds Dr. Bärbel Rohrer to their scientific advisory board. Dr. Rohrer will assist with the design and execution of pivotal animal studies for Ichor’s therapeutic candidates for age-related macular degeneration. “Dr. Rohrer is an addition of incredible value to our advisory team.”

Read more

15
Jun

GLP/GMP is next for Ichor Therapeutics.

In March we signed on a new investor, Roger Bagg (you may have seen our press release over at MedTech, or the Town of Lafayette Newsletter – we’re glad everyone else was as excited as we were!). Roger is an ideal investor for Ichor. He has experience investing in other Biotech firms both in the US and the UK, and philosophically

Read more